Methods and compositions for treating sleep apnea

Described herein are pharmaceutical compositions comprising a noradrenaline reuptake inhibitor (NRI) and a mineralocorticoid antagonist, and optionally a muscarinic receptor antagonist (MRA), and methods of treating sleep apnea. 本文描述了包含去甲肾上腺素再摄取抑制剂(NRI)和盐皮质激素拮抗剂和任选的毒蕈碱受体拮抗剂(MRA)的药物组合物以及治疗睡眠呼吸暂停的方法。...

Full description

Saved in:
Bibliographic Details
Main Authors TARANTO-MONTEMURRO LUIGI, MILLER, LARRY, G, FARKAS, RICHARD
Format Patent
LanguageChinese
English
Published 14.11.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Described herein are pharmaceutical compositions comprising a noradrenaline reuptake inhibitor (NRI) and a mineralocorticoid antagonist, and optionally a muscarinic receptor antagonist (MRA), and methods of treating sleep apnea. 本文描述了包含去甲肾上腺素再摄取抑制剂(NRI)和盐皮质激素拮抗剂和任选的毒蕈碱受体拮抗剂(MRA)的药物组合物以及治疗睡眠呼吸暂停的方法。
Bibliography:Application Number: CN202280024023